Axcella Health Inc Sees IPO Of Up To 3.6 Mln Shares Priced To Be Between $20 And $22 Per Share
April 30 (Reuters) - Axcella Health Inc
Latest Key Developments inBiotechnology
- Vertex And Republic Of Ireland Expand Long-Term Cystic Fibrosis Medicines Reimbursement Agreement
- Athenex Announces Superior Response & Survival With Lower Neuropathy Of A Novel Oral Paclitaxel Versus IV Paclitaxel In Treatment Of Metastatic Breast Cancer
- OncoSec Medical Presents Interim Data From Ongoing Keynote-890 Study Evaluating Tavo In Combination With Keytruda
- Helix Biopharma Reports Q1 Loss Per Share C$0.02